National Research Stock

National Research ROE 2024

National Research ROE

0.63

Ticker

NRC

ISIN

US6373722023

WKN

A1WYXP

In 2024, National Research's return on equity (ROE) was 0.63, a 43.2% increase from the 0.44 ROE in the previous year.

National Research Aktienanalyse

What does National Research do?

The National Research Corporation (NRC) was founded in 1981 and is headquartered in Lincoln, Nebraska, USA. Since its inception, the company has specialized in researching customer opinions and experiences in the healthcare industry and is therefore one of the leading providers in this market. The NRC's business model consists of helping hospitals, nursing homes, and other healthcare facilities better understand and respond to the needs of their patients and employees. Over the years, the National Research Corporation has continuously expanded its range of services. The company now has several divisions, including: - NRC Health: This is NRC's main business area, which focuses on collecting, analyzing, and reporting customer opinions and experiences in the healthcare industry. NRC Health offers various survey and analysis methods to improve the quality of healthcare and increase customer satisfaction. - Transparency Solutions: This division of NRC Health focuses on creating transparency reports and performance comparisons of medical facilities. These reports are helpful for potential patients and their families to make informed decisions about which medical facilities offer the best treatment. - My InnerView: This is an NRC Health platform specifically designed for long-term care facilities. My InnerView offers survey and analysis methods to improve the quality of care and support for residents in nursing homes. - Market Insights: This division of NRC provides healthcare facilities with access to key information about employee hiring and retention, as well as market trends and competitive analysis. - Resident & Family Experience: This division of NRC focuses on capturing customer feedback and experiences in independent and assisted living facilities. By using surveys and feedback analysis, the company can improve resident and family satisfaction and optimize the customer experience in these facilities. In addition to these various divisions, NRC also offers a variety of products to help healthcare facilities improve their customer and employee experiences. These include survey tools, data analysis software, dashboards, and reporting tools. Overall, over the years, the National Research Corporation has built a strong reputation by helping customers in the healthcare industry better understand and respond to the needs of their patients and employees. The company has established itself as a trusted partner that provides valuable insights into healthcare and supports healthcare facilities in improving customer and employee satisfaction. National Research ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding National Research's Return on Equity (ROE)

National Research's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing National Research's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

National Research's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in National Research’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about National Research stock

What is the ROE (Return on Equity) of National Research this year?

The ROE of National Research this year is 0.63 undefined.

How has the Return on Equity (ROE) of National Research developed compared to the previous year?

The ROE of National Research has increased by 43.2% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of National Research?

A high ROE indicates that National Research generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of National Research?

A low ROE can indicate that National Research is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of National Research affect the company?

A change in ROE (Return on Equity) of National Research can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of National Research?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of National Research?

Some factors that can influence National Research's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does National Research pay?

Over the past 12 months, National Research paid a dividend of 1.48 USD . This corresponds to a dividend yield of about 7.41 %. For the coming 12 months, National Research is expected to pay a dividend of 1.48 USD.

What is the dividend yield of National Research?

The current dividend yield of National Research is 7.41 %.

When does National Research pay dividends?

National Research pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of National Research?

National Research paid dividends every year for the past 19 years.

What is the dividend of National Research?

For the upcoming 12 months, dividends amounting to 1.48 USD are expected. This corresponds to a dividend yield of 7.41 %.

In which sector is National Research located?

National Research is assigned to the 'Health' sector.

Wann musste ich die Aktien von National Research kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of National Research from 10/11/2024 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did National Research pay the last dividend?

The last dividend was paid out on 10/11/2024.

What was the dividend of National Research in the year 2023?

In the year 2023, National Research distributed 0.84 USD as dividends.

In which currency does National Research pay out the dividend?

The dividends of National Research are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von National Research

Our stock analysis for National Research Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of National Research Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.